Biography :
David S. Perlin, Ph.D. is Chief Scientific Officer and Senior Vice President of the Center for Discovery and Innovation (CDI); Professor of Medical Sciences at the Hackensack Meridian School of Medicine; Fellow of the New York Academy of Sciences; and Fellow of the American Academy of Microbiology. His research emphasizes studies to diagnose and overcome drug-resistant fungal and bacterial infections in cancer, transplant and other high-risk patients by exploiting insights obtained from molecular investigations of drug resistance, pathogenicity, and host response to improve current therapies and develop novel drugs and diagnostics.

During COVID-19, Perlin and his CDI colleagues were instrumental in developing new diagnostics for the virus and its variants, as well as investigating the potential of convalescent plasma and other therapies.

Register for reporter access to contact details
Relevant Experts